Identification of patients with mood disorder following admission with hip fracture with a view to starting treatment and provide advice

por Giles, Karla Louise, Macpherson, Lisa, Martin-Hernandez, Maria del Pilar, Wilson, Helen, Hall, Philip, Thompson, Keri, Bailey, Sarah
Publicado 2021

Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis

por Coates, Laura C, Smolen, Josef S, Mease, Philip J, Husni, M. Elaine, Merola, Joseph F., Lespessailles, Eric, Kishimoto, Mitsumasa, Macpherson, Lisa, Bradley, Andrew J, Bolce, Rebecca, Helliwell, Philip S.
Publicado 2022

Bamlanivimab and Etesevimab Improve Symptoms and Associated Outcomes in Ambulatory Patients at Increased Risk for Severe Coronavirus Disease 2019: Results From the Placebo-Controll...

por Chen, Peter, Behre, Gerhard, Hebert, Corey, Kumar, Princy, Farmer Macpherson, Lisa, Graham-Clarke, Peita Louise, De La Torre, Inmaculada, Nichols, Russell M, Hufford, Matthew M, Patel, Dipak R, Naegeli, April N
Publicado 2022

Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)

por Orbai, Ana-Maria, Gratacós, Jordi, Turkiewicz, Anthony, Hall, Stephen, Dokoupilova, Eva, Combe, Bernard, Nash, Peter, Gallo, Gaia, Bertram, Clinton C., Gellett, Amanda M., Sprabery, Aubrey Trevelin, Birt, Julie, Macpherson, Lisa, Geneus, Vladimir J., Constantin, Arnaud
Publicado 2020

Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial

por Upadhyaya, Himanshu P., Chien, Jenny Y., Long, Amanda J., Bohm, Martin S., Kallewaard, Nicole L., Macpherson, Lisa F., Patel, Dipak R., Hufford, Matthew M., Krull, Constance J., Ang, Jocelyn Y., Chen, Peter, Muller, William J., Potts, Jeffrey A., Quinn, Timothy, Williams, Mark
Publicado 2023